Literature DB >> 19725081

Exploring chemical substructures essential for HERG k(+) channel blockade by synthesis and biological evaluation of dofetilide analogues.

Dong Guo, Elisabeth Klaasse, Henk de Vries, Johannes Brussee, Lukás Nalos, Martin B Rook, Marc A Vos, Marcel A G van der Heyden, Adriaan P Ijzerman.   

Abstract

In this study we followed a new approach to analyze molecular substructures required for hERG channel blockade. We designed and synthesized 40 analogues of dofetilide (1), a potent hERG potassium channel blocker, and established structure-activity relationships (SAR) for their interaction with this important cardiotoxicity-related off-target. Structural modifications to dofetilide were made by diversifying the substituents on the phenyl rings and the protonated nitrogen and by varying the carbon chain length. The analogues were evaluated in a radioligand binding assay and SAR data were derived with the aim to specify structural features that give rise to hERG toxicity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19725081     DOI: 10.1002/cmdc.200900203

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  5 in total

1.  Kv 11.1 (hERG)-induced cardiotoxicity: a molecular insight from a binding kinetics study of prototypical Kv 11.1 (hERG) inhibitors.

Authors:  Z Yu; A P IJzerman; L H Heitman
Journal:  Br J Pharmacol       Date:  2014-12-15       Impact factor: 8.739

2.  Control of Biophysical and Pharmacological Properties of Potassium Channels by Ancillary Subunits.

Authors:  Geoffrey W Abbott
Journal:  Handb Exp Pharmacol       Date:  2021

3.  Correlation between human ether-a-go-go-related gene channel inhibition and action potential prolongation.

Authors:  P Saxena; M P Hortigon-Vinagre; S Beyl; I Baburin; S Andranovits; S M Iqbal; A Costa; A P IJzerman; P Kügler; E Timin; G L Smith; S Hering
Journal:  Br J Pharmacol       Date:  2017-08-11       Impact factor: 9.473

4.  Structure-activity relationships of pentamidine-affected ion channel trafficking and dofetilide mediated rescue.

Authors:  R Varkevisser; M J C Houtman; T Linder; K C G de Git; H D M Beekman; R R Tidwell; A P Ijzerman; A Stary-Weinzinger; M A Vos; M A G van der Heyden
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 9.473

5.  Assessing hERG pore models as templates for drug docking using published experimental constraints: the inactivated state in the context of drug block.

Authors:  Christopher E Dempsey; Dominic Wright; Charlotte K Colenso; Richard B Sessions; Jules C Hancox
Journal:  J Chem Inf Model       Date:  2014-02-06       Impact factor: 4.956

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.